Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 Carriers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03495609
Recruitment Status : Completed
First Posted : April 12, 2018
Last Update Posted : August 28, 2019
Sponsor:
Collaborators:
Fox Chase Cancer Center
Ziekenhuis Oost-Limburg
Information provided by (Responsible Party):
Steven Weyers, MD, PhD, University Hospital, Ghent

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 18, 2018
Actual Study Completion Date : December 18, 2018